Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,809 | 1,355 | 98.6% |
| Education | $320.60 | 18 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,297 | 136 | $0 (2024) |
| Novo Nordisk Inc | $1,680 | 114 | $0 (2024) |
| Lilly USA, LLC | $1,543 | 86 | $0 (2024) |
| Amgen Inc. | $1,491 | 72 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,317 | 76 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,158 | 125 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,064 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,037 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $891.01 | 61 | $0 (2024) |
| Amarin Pharma Inc. | $730.29 | 37 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,264 | 173 | ABBVIE INC. ($325.35) |
| 2023 | $3,081 | 198 | ABBVIE INC. ($564.12) |
| 2022 | $2,702 | 159 | ABBVIE INC. ($614.33) |
| 2021 | $2,656 | 181 | AbbVie Inc. ($670.60) |
| 2020 | $2,584 | 163 | Allergan, Inc. ($300.65) |
| 2019 | $3,315 | 195 | Novo Nordisk Inc ($355.85) |
| 2018 | $3,172 | 164 | Amgen Inc. ($430.77) |
| 2017 | $2,355 | 140 | Amgen Inc. ($351.14) |
All Payment Transactions
1,373 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: NEUROLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: PAIN | ||||||
| 11/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PAIN | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 11/16/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 11/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.47 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,018 | 1,543 | $204,068 | $117,332 |
| 2022 | 13 | 978 | 1,684 | $216,057 | $127,742 |
| 2021 | 13 | 913 | 1,528 | $183,190 | $112,907 |
| 2020 | 11 | 822 | 1,477 | $203,185 | $104,181 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 338 | 774 | $92,880 | $47,135 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 246 | 246 | $46,248 | $32,787 | 70.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 153 | $26,928 | $14,608 | 54.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 90 | 90 | $8,130 | $6,377 | 78.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $5,896 | $3,769 | 63.9% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 11 | 38 | $7,904 | $3,243 | 41.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $5,236 | $3,118 | 59.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 93 | 93 | $3,720 | $2,739 | 73.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 68 | $5,032 | $2,653 | 52.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 12 | $1,044 | $519.72 | 49.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 18 | $630.00 | $211.32 | 33.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $420.00 | $172.15 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 324 | 943 | $113,160 | $60,010 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 242 | 242 | $45,496 | $33,412 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 124 | $21,824 | $12,317 | 56.4% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 14 | 55 | $11,440 | $5,351 | 46.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 70 | 70 | $4,900 | $4,798 | 97.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $5,360 | $3,528 | 65.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 94 | $3,760 | $2,659 | 70.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 15 | $3,975 | $2,623 | 66.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 42 | 47 | $3,478 | $1,870 | 53.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 21 | 21 | $630.00 | $421.47 | 66.9% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2022 | 16 | 18 | $900.00 | $349.67 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 22 | $770.00 | $243.58 | 31.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $364.00 | $158.97 | 43.7% |
About Dr. Joseph Labricciosa, DO
Dr. Joseph Labricciosa, DO is a Family Medicine healthcare provider based in Broomall, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053315523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Labricciosa, DO has received a total of $23,129 in payments from pharmaceutical and medical device companies, with $3,264 received in 2024. These payments were reported across 1,373 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($22,809).
As a Medicare-enrolled provider, Labricciosa has provided services to 3,731 Medicare beneficiaries, totaling 6,232 services with total Medicare billing of $462,161. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Broomall, PA
- Active Since 06/13/2005
- Last Updated 02/21/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053315523
Products in Payments
- VRAYLAR (Drug) $1,171
- JARDIANCE (Drug) $1,120
- XIFAXAN (Drug) $1,075
- TRULICITY (Drug) $824.78
- Ozempic (Drug) $768.66
- Vascepa (Drug) $730.29
- UBRELVY (Drug) $728.38
- TRELEGY ELLIPTA (Drug) $702.79
- FARXIGA (Drug) $628.42
- XARELTO (Drug) $619.98
- TROKENDI XR (Drug) $487.02
- NURTEC ODT (Drug) $431.74
- JANUVIA (Drug) $386.80
- CAPLYTA (Drug) $385.52
- LINZESS (Drug) $376.17
- Aimovig (Biological) $374.79
- Repatha (Biological) $356.57
- Natesto (Drug) $352.86
- REXULTI (Drug) $352.81
- Prolia (Biological) $339.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broomall
Dr. Scott Kurzrok, Do, DO
Family Medicine — Payments: $25,518
Dr. Joshua Feinberg, Do, DO
Family Medicine — Payments: $11,348
Dr. Donna Delfin, Do, DO
Family Medicine — Payments: $8,705
Dr. Dionne Curran-Chamoun, D.o, D.O
Family Medicine — Payments: $960.68
Dr. Mark Monaco, D.o, D.O
Family Medicine — Payments: $776.12
Phillip Dobson, Md, MD
Family Medicine — Payments: $511.30